Screener
Kiniksa Pharmaceuticals International, plc KNSA EV / EBITDA
EV / EBITDA at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
Based on the most recent quarter.
The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026. Open the filing →
- Filed
- Jul 28, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-087545
FAQ
- What is Kiniksa Pharmaceuticals International, plc's EV / EBITDA?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported EV / EBITDA of 46.6× in Q2 2026.
- How has Kiniksa Pharmaceuticals International, plc's EV / EBITDA changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's EV / EBITDA decreased by 85.6% year-over-year, from 324.3× to 46.6×.
- What does EV / EBITDA mean?
- Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.
Ask your AI about Kiniksa Pharmaceuticals International, plc's ev / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude